Document
IPR2022-00855, No. 2041 Exhibit - Renier J Brentjens et al, Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts, 13 CLINICAL CANCER RSCH 5426 2007...
Cite Document
IPR2022-00855, No. 2041 Exhibit - Renier J Brentjens et al, Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts, 13 CLINICAL CANCER RSCH 5426 2007 (P.T.A.B. Jul. 19
+ More Snippets
Document
IPR2022-00855, No. 2015 Exhibit - Jennifer Couzin Frankel, The dizzying journey to a new cancer arsenal, 340 SCI 1514 2013 (P.T.A.B. Jul. 19, 2022)
Cite Document
IPR2022-00855, No. 2015 Exhibit - Jennifer Couzin Frankel, The dizzying journey to a new cancer arsenal, 340 SCI 1514 2013 (P.T.A.B. Jul. 19, 2022)
+ More Snippets
Document
IPR2022-00855, No. 2075 Exhibit - EX 2075 (P.T.A.B. Feb. 13, 2023)
Cite Document
IPR2022-00855, No. 2075 Exhibit - EX 2075 (P.T.A.B. Feb. 13, 2023)
+ More Snippets
Document
IPR2022-00855, No. 2067 Exhibit - EX 2067 (P.T.A.B. Feb. 13, 2023)
Cite Document
IPR2022-00855, No. 2067 Exhibit - EX 2067 (P.T.A.B. Feb. 13, 2023)
+ More Snippets
Document
IPR2022-00855, No. 2060 Exhibit - EX 2060 (P.T.A.B. Feb. 13, 2023)
Cite Document
IPR2022-00855, No. 2060 Exhibit - EX 2060 (P.T.A.B. Feb. 13, 2023)
+ More Snippets
Document
IPR2022-00855, No. 2076 Exhibit - EX 2076 (P.T.A.B. Feb. 13, 2023)
Cite Document
IPR2022-00855, No. 2076 Exhibit - EX 2076 (P.T.A.B. Feb. 13, 2023)
+ More Snippets
Document
IPR2022-00855, No. 2069 Exhibit - EX 2069 (P.T.A.B. Feb. 13, 2023)
Cite Document
IPR2022-00855, No. 2069 Exhibit - EX 2069 (P.T.A.B. Feb. 13, 2023)
+ More Snippets
Document
IPR2022-00855, No. 2058 Exhibit - EX 2058 (P.T.A.B. Feb. 13, 2023)
Cite Document
IPR2022-00855, No. 2058 Exhibit - EX 2058 (P.T.A.B. Feb. 13, 2023)
+ More Snippets
Document
IPR2022-00855, No. 2049 Exhibit - EX 2049 (P.T.A.B. Feb. 13, 2023)
Cite Document
IPR2022-00855, No. 2049 Exhibit - EX 2049 (P.T.A.B. Feb. 13, 2023)
+ More Snippets
Document
IPR2022-00855, No. 2065 Exhibit - EX 2065 (P.T.A.B. Feb. 13, 2023)
Cite Document
IPR2022-00855, No. 2065 Exhibit - EX 2065 (P.T.A.B. Feb. 13, 2023)
+ More Snippets
Document
IPR2022-00855, No. 2050 Exhibit - EX 2050 (P.T.A.B. Feb. 13, 2023)
Cite Document
IPR2022-00855, No. 2050 Exhibit - EX 2050 (P.T.A.B. Feb. 13, 2023)
+ More Snippets
Document
IPR2022-00855, No. 1013 Exhibit - Porter Protocol (P.T.A.B. Apr. 12, 2022)
Cite Document
IPR2022-00855, No. 1013 Exhibit - Porter Protocol (P.T.A.B. Apr. 12, 2022)
+ More Snippets
Document
IPR2022-00855, No. 2042 Exhibit - US Patent No 7,402,431 (P.T.A.B. Jul. 19, 2022)
Cite Document
IPR2022-00855, No. 2042 Exhibit - US Patent No 7,402,431 (P.T.A.B. Jul. 19, 2022)
+ More Snippets
Document
IPR2022-00855, No. 2035 Exhibit - Grazyna Lipowska Bhalla, Targeted immunotherapy of cancer with CAR T cells achievements and challenges, 61 CANCER IMMUNOLOGY, IMMUNOTHERAP...
Cite Document
IPR2022-00855, No. 2035 Exhibit - Grazyna Lipowska Bhalla, Targeted immunotherapy of cancer with CAR T cells achievements and challenges, 61 CANCER IMMUNOLOGY, IMMUNOTHERAPY 953 2012 (P.T.A.B. Jul. 19
+ More Snippets
Document
IPR2022-00855, No. 2007 Exhibit - FOOD AND DRUG ADMIN, FDA APPROVAL BRINGS FIRST GENE THERAPY TO THE UNITED STATES Aug 30, 2017, httpswwwfdagovnews eventspress ann...
Cite Document
IPR2022-00855, No. 2007 Exhibit - FOOD AND DRUG ADMIN, FDA APPROVAL BRINGS FIRST GENE THERAPY TO THE UNITED STATES Aug 30, 2017, httpswwwfdagovnews eventspress announcementsfda approval brings first g
+ More Snippets